Kymera Therapeutics
KYMR
$37.40
Share price
3.03%
Change (1 day)
21.04%
Change (1 year)
Categories
Kymera Therapeutics (KYMR) - Total assets
Total assets on the balance sheet as of December 2023 : $0.57 B
According to Kymera Therapeutics's latest financial reports the company's total assets are $0.57 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Kymera Therapeutics - Total assets on balance sheet (from 2019 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.57 B | -4.54% |
| 2022-12-31 | $0.60 B | -0.46% |
| 2021-12-31 | $0.60 B | 24.37% |
| 2020-12-31 | $0.48 B | 317.45% |
| 2019-12-31 | $0.11 B | 163.85% |
| 2018-12-31 | $44.23 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.25 B | -56.23% | 🇺🇸 USA |